Results 141 to 150 of about 854,361 (341)

The state of genetic counseling supervision worldwide: Challenges, practices, and pathways for the future. [PDF]

J Genet Couns
Guimarães L, Ribeiro B, Henriques MR, Lemos MS, Paneque M.   +4 more
europepmc   +1 more source

EFEKTIVITAS STRATEGI HOLLAND TYPES FOR CAREER COUNSELING DAN STRATEGI SOLUTION-FOCUSED CAREER COUNSELING UNTUK PENINGKATAN KEMATANGAN KARIR [PDF]

, 2015
Diah Susilawati
openalex  

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Behavioral Counseling to Prevent Skin Cancer: US Preventive Services Task Force Recommendation Statement

Journal of the American Medical Association (JAMA), 2018
D. Grossman, S. Curry, D. Owens, M. Barry, A. Caughey, K. Davidson, Chyke A Doubeni, J. Epling, A. Kemper, A. Krist, Martha Y. Kubik, S. Landefeld, C. Mangione, Michael Silverstein, M. Simon, Chien-Wen Tseng   +15 more
semanticscholar   +1 more source

A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy

Molecular Oncology, EarlyView.
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti, Giovanni Germano, Pietro Paolo Vitiello, Alberto Bardelli   +3 more
wiley   +1 more source

Exploring the principles of logotherapy in genetic counseling: Enhancing decision-making, adaptation, and justice. [PDF]

J Genet Couns
Chanouha N, Chassevent A, Macnamara EF, Schaa K, Thoeny R, Tansey J.   +5 more
europepmc   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

Paths of legal recognition of genetic counselors in Canada: A framework for action. [PDF]

J Genet Couns
Patrinos D, Bonilha AE, Knoppers BM, Elliott AM, GenCOUNSEL Study, Zawati MH.   +5 more
europepmc   +1 more source

Exploring Workplace Mental Health and Counseling Needs in Open University Staff: A Mixed-Methods Study

Pathanin Sangaroon, Oranuch Kanjanaprakorn, Araya Prasertchai, Worrawit Nakpan   +3 more
openalex   +1 more source

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma

Molecular Oncology, EarlyView.
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken, Andrea Abel Gutierrez, Imke van Rossum, Cornelia G. Spruijt, Michiel Vermeulen, Guido van Mierlo, Blanca Scheijen, Annemiek B. van Spriel   +7 more
wiley   +1 more source